401 related articles for article (PubMed ID: 15710243)
41. Gene expression of iron-related proteins during iron deficiency caused by scurvy in guinea pigs.
Gosiewska A; Mahmoodian F; Peterkofsky B
Arch Biochem Biophys; 1996 Jan; 325(2):295-303. PubMed ID: 8561510
[TBL] [Abstract][Full Text] [Related]
42. Aging-related changes in the iron status of skeletal muscle.
DeRuisseau KC; Park YM; DeRuisseau LR; Cowley PM; Fazen CH; Doyle RP
Exp Gerontol; 2013 Nov; 48(11):1294-302. PubMed ID: 23994517
[TBL] [Abstract][Full Text] [Related]
43. Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.
Brodie C; Siriwardana G; Lucas J; Schleicher R; Terada N; Szepesi A; Gelfand E; Seligman P
Cancer Res; 1993 Sep; 53(17):3968-75. PubMed ID: 8358725
[TBL] [Abstract][Full Text] [Related]
44. Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury.
Rothman RJ; Serroni A; Farber JL
Mol Pharmacol; 1992 Oct; 42(4):703-10. PubMed ID: 1435746
[TBL] [Abstract][Full Text] [Related]
45. Sulfide increases labile iron pool in RD4 cells.
Hälldin J; Land T
Biometals; 2008 Apr; 21(2):127-31. PubMed ID: 17546407
[TBL] [Abstract][Full Text] [Related]
46. Iron regulatory protein 1 outcompetes iron regulatory protein 2 in regulating cellular iron homeostasis in response to nitric oxide.
Styś A; Galy B; Starzyński RR; Smuda E; Drapier JC; Lipiński P; Bouton C
J Biol Chem; 2011 Jul; 286(26):22846-54. PubMed ID: 21566147
[TBL] [Abstract][Full Text] [Related]
47. Increased expression of glial cell line-derived neurotrophic factor (GDNF) in the brains of scrapie-infected mice.
Lee YJ; Jin JK; Jeong BH; Carp RI; Kim YS
Neurosci Lett; 2006 Dec; 410(3):178-82. PubMed ID: 17101222
[TBL] [Abstract][Full Text] [Related]
48. Temporal responses in the disruption of iron regulation by manganese.
Kwik-Uribe C; Smith DR
J Neurosci Res; 2006 Jun; 83(8):1601-10. PubMed ID: 16568477
[TBL] [Abstract][Full Text] [Related]
49. Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload.
Wallace DF; Summerville L; Subramaniam VN
Gastroenterology; 2007 Jan; 132(1):301-10. PubMed ID: 17241880
[TBL] [Abstract][Full Text] [Related]
50. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
Wiesinger JA; Buwen JP; Cifelli CJ; Unger EL; Jones BC; Beard JL
J Neurochem; 2007 Jan; 100(1):167-79. PubMed ID: 17227437
[TBL] [Abstract][Full Text] [Related]
51. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
[TBL] [Abstract][Full Text] [Related]
52. Redox control of iron regulatory protein 2 stability.
Hausmann A; Lee J; Pantopoulos K
FEBS Lett; 2011 Feb; 585(4):687-92. PubMed ID: 21281640
[TBL] [Abstract][Full Text] [Related]
53. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
54. Iron regulatory protein 1 is not required for the modulation of ferritin and transferrin receptor expression by iron in a murine pro-B lymphocyte cell line.
Schalinske KL; Blemings KP; Steffen DW; Chen OS; Eisenstein RS
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10681-6. PubMed ID: 9380695
[TBL] [Abstract][Full Text] [Related]
55. Foot-shock stress-induced regional iron accumulation and altered iron homeostatic mechanisms in rat brain.
Ma L; Wang W; Zhao M; Li M
Biol Trace Elem Res; 2008; 126(1-3):204-13. PubMed ID: 18709494
[TBL] [Abstract][Full Text] [Related]
56. Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum: expression and regulation in hereditary hemochromatosis and iron deficiency.
Recalcati S; Alberghini A; Campanella A; Gianelli U; De Camilli E; Conte D; Cairo G
Haematologica; 2006 Mar; 91(3):303-10. PubMed ID: 16503547
[TBL] [Abstract][Full Text] [Related]
57. Nitric oxide inhibits the degradation of IRP2.
Wang J; Chen G; Pantopoulos K
Mol Cell Biol; 2005 Feb; 25(4):1347-53. PubMed ID: 15684386
[TBL] [Abstract][Full Text] [Related]
58. Transferrin receptor-1 suppresses neurite outgrowth in neuroblastoma Neuro2A cells.
Nakamura Y; Nakamichi N; Takarada T; Ogita K; Yoneda Y
Neurochem Int; 2012 Apr; 60(5):448-57. PubMed ID: 22019713
[TBL] [Abstract][Full Text] [Related]
59. Iron regulatory proteins and the molecular control of mammalian iron metabolism.
Eisenstein RS
Annu Rev Nutr; 2000; 20():627-62. PubMed ID: 10940348
[TBL] [Abstract][Full Text] [Related]
60. IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice.
Corna G; Galy B; Hentze MW; Cairo G
J Mol Med (Berl); 2006 Jul; 84(7):551-60. PubMed ID: 16770644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
